Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $4,700 | 3 | 48.2% |
| Food and Beverage | $4,655 | 36 | 47.8% |
| Travel and Lodging | $315.00 | 1 | 3.2% |
| Education | $75.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fisher Scientific Company L.L.C. | $5,952 | 7 | $0 (2024) |
| ABBVIE INC. | $689.43 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $426.39 | 4 | $0 (2023) |
| Stryker Corporation | $282.46 | 2 | $0 (2023) |
| The Medicines Company | $227.69 | 2 | $0 (2017) |
| Chiesi USA, Inc. | $201.26 | 2 | $0 (2024) |
| SOBI, INC | $200.74 | 2 | $0 (2024) |
| Kerecis Limited | $149.92 | 1 | $0 (2024) |
| Medtronic, Inc. | $133.24 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $128.34 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,312 | 14 | Fisher Scientific Company L.L.C. ($3,252) |
| 2023 | $3,754 | 11 | Fisher Scientific Company L.L.C. ($2,700) |
| 2022 | $350.91 | 3 | AstraZeneca Pharmaceuticals LP ($225.93) |
| 2021 | $114.99 | 1 | La Jolla Pharmaceutical Company ($114.99) |
| 2019 | $317.81 | 3 | Alexion Pharmaceuticals, Inc. ($122.07) |
| 2018 | $544.89 | 6 | Stryker Corporation ($129.92) |
| 2017 | $351.42 | 3 | The Medicines Company ($227.69) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 08/06/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $87.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2024 | SOBI, INC | GAMIFANT (Drug) | Food and Beverage | In-kind items and services | $124.75 | General |
| Category: HEMATOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/16/2024 | SOBI, INC | GAMIFANT (Drug) | Education | In-kind items and services | $75.99 | General |
| Category: HEMATOLOGY | ||||||
| 06/28/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $149.92 | General |
| Category: Wound Care | ||||||
| 04/03/2024 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 03/07/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Honoraria | In-kind items and services | $2,000.00 | General |
| Category: Infectious Disease | ||||||
| 03/07/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Food and Beverage | In-kind items and services | $666.42 | General |
| Category: Infectious Disease | ||||||
| 03/07/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Travel and Lodging | In-kind items and services | $315.00 | General |
| Category: Infectious Disease | ||||||
| 03/07/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Food and Beverage | In-kind items and services | $165.19 | General |
| Category: Infectious Disease | ||||||
| 02/20/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/13/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Food and Beverage | In-kind items and services | $105.25 | General |
| Category: Infectious Disease | ||||||
| 12/07/2023 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Honoraria | In-kind items and services | $1,500.00 | General |
| Category: Infectious Disease | ||||||
| 12/04/2023 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $125.12 | General |
| Category: Structural Heart | ||||||
| 11/08/2023 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/25/2023 | Stryker Corporation | PHYSIO - LUCAS (Device) | Food and Beverage | In-kind items and services | $152.54 | General |
| Category: PHYSIO | ||||||
| 07/19/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $133.24 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/28/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $116.59 | General |
| 05/17/2023 | AbbVie Inc. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $73.04 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/28/2023 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Honoraria | In-kind items and services | $1,200.00 | General |
| Category: Infectious Disease | ||||||
| 04/19/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $83.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/22/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $117.41 | General |
| Category: Rare Disease | ||||||
| 01/11/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug) | Food and Beverage | In-kind items and services | $128.34 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 111 | 173 | $150,754 | $25,891 |
| 2022 | 2 | 163 | 274 | $218,561 | $43,050 |
| 2021 | 3 | 131 | 211 | $182,539 | $33,293 |
| 2020 | 3 | 83 | 110 | $106,197 | $15,193 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 76 | 137 | $111,487 | $22,805 | 20.5% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 21 | 22 | $38,114 | $2,997 | 7.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 14 | 14 | $1,153 | $88.44 | 7.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 128 | 234 | $201,421 | $39,827 | 19.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 40 | $17,140 | $3,223 | 18.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 104 | 180 | $175,000 | $32,012 | 18.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 14 | $6,230 | $1,169 | 18.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 14 | 17 | $1,309 | $112.26 | 8.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 46 | 70 | $80,461 | $13,128 | 16.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 13 | 13 | $23,707 | $1,871 | 7.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 24 | 27 | $2,028 | $193.93 | 9.6% |
About Dr. Patrick Cullinan, DO
Dr. Patrick Cullinan, DO is a Emergency Medicine healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043389653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Cullinan, DO has received a total of $9,746 in payments from pharmaceutical and medical device companies, with $4,312 received in 2024. These payments were reported across 41 transactions from 22 companies. The most common payment nature is "Honoraria" ($4,700).
As a Medicare-enrolled provider, Cullinan has provided services to 488 Medicare beneficiaries, totaling 768 services with total Medicare billing of $117,427. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Critical Care Medicine
- Location San Antonio, TX
- Active Since 11/07/2006
- Last Updated 06/22/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1043389653
Products in Payments
- Procalcitonin (Device) $5,952
- AVYCAZ (Drug) $249.82
- ANDEXXA (Biological) $218.35
- CLEVIPREX (Drug) $201.26
- GAMIFANT (Drug) $200.74
- TEFLARO (Drug) $198.03
- PHYSIO - LUCAS (Device) $152.54
- Kerecis Omega3 SurgiClose (Device) $149.92
- LINQ II (Device) $133.24
- TREVO (Device) $129.92
- Ongentys (Drug) $128.34
- AMPLATZER AMULET (Device) $125.12
- UPTRAVI (Drug) $125.00
- BRILINTA (Drug) $124.99
- Nephrocheck (Device) $124.99
- GABLOFEN (Drug) $124.98
- OFIRMEV (Drug) $123.73
- VABOMERE (Drug) $123.72
- SOLIRIS (Drug) $122.07
- RELIZORB (Device) $121.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in San Antonio
James Williams, D.o, D.O
Emergency Medicine — Payments: $443,586
Brian Macgillivray, Md, MD
Emergency Medicine — Payments: $102,065
Dr. Grant Garbo, M.d, M.D
Emergency Medicine — Payments: $29,315
Dr. Christine Zink, Md, MD
Emergency Medicine — Payments: $27,012
Dr. David Miramontes, M.d, M.D
Emergency Medicine — Payments: $26,434
Robert Wiggins, Md, MD
Emergency Medicine — Payments: $21,103